Tender Offers for Gossamer Bio, Inc.

Form Type: 8-K

Filing Date: 2024-05-06

Corporate Action: Tender-offer

Type: New

Accession Number: 000172811724000052

Comments: This announcement details the collaboration agreement between Gossamer Bio, Inc. and Chiesi Farmaceutici, including a financial aspect where Chiesi has the option to purchase up to 9.9% of Gossamer's common stock. The agreement includes a significant payment of $160 million and potential milestone payments. It is structured as a global collaboration to develop and commercialize a new product. The document discusses various aspects of development, commercialization, and financing obligations. It is a significant tender offer with a current expiration date for exercising options to trigger the acquisition. The parties are planning to share profits equally in the US but have different arrangements in other territories.

Document Link: View Document